20
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Long-term outcomes following mitral valve replacement in children at heart center Leipzig: a 20-year analysis

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Although mitral valve repair is the preferred surgical strategy in children with mitral valve disease, there are cases of irreparable severe dysplastic valves that require mitral valve replacement. The aim of this study is to analyze long-term outcomes following mitral valve replacement in children in a tertiary referral center.

          Methods

          A total of 41 consecutive patients underwent mitral valve replacement between February 2001 and February 2021. The study data was prospectively collected and retrospectively analyzed. Primary outcomes were in-hospital mortality, long-term survival, and long-term freedom from reoperation.

          Results

          Median age at operation was 23 months (IQR 5–93), median weight was 11.3 kg (IQR 4.8–19.4 kg). One (2.4%) patient died within the first 30 postoperative days. In-hospital mortality was 4.9%. Four (9.8%) patients required re-exploration for bleeding, and 2 (4.9%) patients needed extracorporeal life support. Median follow-up was 11 years (IQR 11 months − 16 years). Long-term freedom from re-operation after 1, 5, 10 and 15 years was 97.1%, 93.7%, 61.8% and 42.5%, respectively. Long-term survival after 1, 5, 10 and 15 years was 89.9%, 87%, 87% and 80.8%, respectively.

          Conclusion

          If MV repair is not feasible, MV replacement offers a good surgical alternative for pediatric patients with MV disease. It provides good early- and long-term outcomes.

          Related collections

          Most cited references8

          • Record: found
          • Abstract: found
          • Article: not found

          Outcomes of Mechanical Mitral Valve Replacement in Children

          Mitral valve anomalies in children are rare but frequently severe, recalcitrant and not often amenable to primary repair, necessitating mechanical mitral valve replacement (M-MVR). This study examines outcomes of a cohort undergoing 1 st M-MVR at 90 days post-M-MVR, transplant-free survival was 76% at 20 years follow-up (median follow-up: 16.6, IQR: 11.9-21.3). Adjusted analysis in those who survived >90 days showed elevated risk of death/transplant for males (HR 1.5; 95% CI:1.0-2.3), age at M-MVR <2 years [10 year survival, HR 4.3 (95%CI: 1.2 - 15.1)], and non-bi-leaflet prosthesis placement (HR 2.4; 95% CI: 1.3-4.3). M-MVR is a viable strategy in children with unrepairable mitral valve disease. Age <2 years at 1 st M-MVR is associated with significant early risk of death and poorer longterm survival.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Evolution of Mitral Valve Replacement in Children: A 40-Year Experience

            This report reviews our 40-year experience with pediatric mitral valve replacement (MVR) with respect to mortality, valve-related morbidity, and reoperation risk factors.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Mitral-valve replacement in children under 6 years of age.

              In patients with congenital mitral-valve disease, reconstructive surgery is the primary goal. However, in cases with severely dysplastic valves or failed repair, mitral-valve replacement (MVR) is the only option. We analyzed, retrospectively, data of 35 patients younger than 6 years of age, who underwent MVR at our institution. Between 1974 and 1997, 35 children underwent MVR. The ages ranged from 2.7 months to 5.5 years (mean=1. 9+/-1.7 years) and body weight varied between 3.2 and 16.7 kg (mean=8.2+/-4 kg). The main indication (57%) for valve replacement was severe mitral-valve insufficiency. Eighteen patients (51%) had undergone at least one previous reconstructive operation (mean=1. 46+/-1.86 years) before the MVR. In 29 cases (83%), mechanical prostheses were implanted. Six patients received a bioprosthesis. The size of the prostheses ranged between 14 and 27 mm. The overall hospital mortality was 17.1% (6/35), and decreased from 33 (1974-1985) to 11.5% (1986-1997). Seven children died late. The actuarial survival after 20 years was 51.2+/-13.3%. Eight patients (23%) required 10 reoperations (8.2%/100 patient-years). Freedom from reoperation at 10 years was 50+/-22%. Valve-related complications were thrombo-embolism (n=2; 1.6%/100 patient-years), hemorrhage (n=1; 0.8%/100 patient-years), structural deterioration (n=3; 2.5%/100 patient-years) and non-structural dysfunction (n=3; 2. 5%/100 patient-years). Follow-up is 96% complete, with a total of 122 patient-years (mean=4.2+/-4.7 years). Eighty six percent of the patients are in New York Heart Association (NYHA) class I, 95% have sinus rhythm and 59% do not need medication. All survivors, except for those who received a bioprosthesis, were placed on a regimen of Phenprocoumon (Marcumar((R))), aiming to maintain the International Normalized Ratio (INR) between 2.5 and 3.5. In one third of these children, self-management of oral anticoagulation was performed either by the patients or their parents. MVR in small children still carries a high risk. In our experience, the long-term results are satisfying. After failed reconstructive surgery, or as a primary procedure, we prefer mechanical prostheses. They are well tolerated and the incidence of anticoagulation-related complications is low.
                Bookmark

                Author and article information

                Contributors
                marcel.vollroth@helios-gesundheit.de
                Journal
                J Cardiothorac Surg
                J Cardiothorac Surg
                Journal of Cardiothoracic Surgery
                BioMed Central (London )
                1749-8090
                3 July 2024
                3 July 2024
                2024
                : 19
                : 419
                Affiliations
                [1 ]Department of Cardiac Surgery, Leipzig Heart Center, Leipzig University, ( https://ror.org/03s7gtk40) Leipzig, Germany
                [2 ]GRID grid.9647.c, ISNI 0000 0004 7669 9786, Department of Pediatric Cardiology, , Leipzig Heart Center, ; Leipzig, Germany
                Article
                2904
                10.1186/s13019-024-02904-7
                11221183
                38961486
                9c01a1e3-86d9-44ba-9bb1-3671300977ad
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 2 January 2024
                : 15 June 2024
                Funding
                Funded by: Universität Leipzig (1039)
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2024

                Surgery
                pediatric cardiac surgery,mitral valve replacement,mitral valve disease, mitral valve surgery

                Comments

                Comment on this article

                scite_
                0
                0
                0
                0
                Smart Citations
                0
                0
                0
                0
                Citing PublicationsSupportingMentioningContrasting
                View Citations

                See how this article has been cited at scite.ai

                scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

                Similar content190

                Most referenced authors105